Litcius/Paper detail

Increased RAB31 Expression in Cancer-Associated Fibroblasts Promotes Colon Cancer Progression Through HGF-MET Signaling

Tang Yang, Zhiheng Huang, Wang Zhanhuai, Xiao Qian, Yue Liu, Xiaoxu Ge, Jingsun Wei, Shu Zheng, Kefeng Ding

2020Frontiers in Oncology33 citationsDOIOpen Access PDF

Abstract

RAB family proteins participate in the dynamic regulation of cellular membrane compartments and are dysregulated in a variety of tumor types, which may alter the biological properties of cancer cells such as proliferation, migration and invasion. In our previous study, we found that Ras-related protein Rab-31 (RAB31) expression was increased in late-stage colorectal cancer (CRC). The role of RAB31 has never been investigated in CRC. In this study, we found that expression of RAB31 in the tumor stroma but not cancer cells of colon cancer predicted poor survival. RAB31 can be detected in primary cancer-associated fibroblasts (CAFs) and paired normal fibroblasts. Conditioned medium (CM) from RAB31 overexpressing CAFs significantly promoted migration of colon cancer cell lines in vitro and in vivo. This process may be mediated by paracrine action of hepatocyte growth factor (HGF), which was increased in the CM of RAB31 overexpressing CAFs. Blockade of HGF/MET signaling by drug inhibition, knockdown of mesenchymal to epithelial transition factor (MET) in RKO or antibody neutralization of HGF abolished migration of RKO cells mediated by RAB31 expression in CAFs. We propose that in colon cancer, increased RAB31 expression in CAFs may contribute to tumor progression by regulating the secretion of HGF in the tumor stroma.

Topics & Concepts

Hepatocyte growth factorParacrine signallingCancer researchFibroblast activation protein, alphaColorectal cancerEndocrinologyMedicineInternal medicineCancerStromaChemistryImmunohistochemistryReceptorCaveolin-1 and cellular processesMicrotubule and mitosis dynamicsEndoplasmic Reticulum Stress and Disease
Increased RAB31 Expression in Cancer-Associated Fibroblasts Promotes Colon Cancer Progression Through HGF-MET Signaling | Litcius